Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
111.6 CHF | -.--% |
|
-.--% | -.--% |
Jul. 09 | RBC Cuts Price Target on Neurocrine Biosciences to $136 From $141, Keeps Sector Perform Rating | MT |
Jul. 03 | ANALYST RECOMMENDATIONS : Alphabet, Nike, Nvidia, Tesla, Starbucks... | ![]() |